Kaken Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Kaken Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kaken Pharmaceutical Co Ltd Strategy Report
- Understand Kaken Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Kaken Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 30 Nov 2021 | Kaken Pharma Acquires ARTham Therapeutics | Acquisition |
Kaken Pharmaceutical Co Ltd
|
ARTham Therapeutics Inc
|
| 01 Jul 2021 | Almirall Enters into Licensing Agreement with Kaken Pharma | Licensing Agreement |
Almirall SA
|
Kaken Pharmaceutical Co Ltd |
| 29 Jan 2021 | Genex Announces Third-Party Allotment of Shares | Equity Offering |
Kaken Pharmaceutical Co Ltd
|
genex inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer